Robert Barthel is a Veterinary Science Consultant at ImpriMed. Robert was previously the Chief Scientific Officer at OncoBioTek from January 2009 to May 2018.
Robert Barthel earned their Docteur en Médecine Vétérinaire (DVM) from the Université de Liège Faculté de Médecine Vétérinaire. Robert then completed a certificate in the Veterinary Pathology Residency Program at Texas A&M University. Afterwards, they earned their Ph.D. in the Infectious Diseases Research Group at Texas A&M University. Currently, they are working as a Post-Doctoral Research Associate at the Center for Blood Reseach Harvard Medical School.